Ongoing
Ongoing
- EPIRNATHER - PN-IV-P1-PCE-2023 - Advanced therapeutic strategy in atherosclerosis based on epitranscriptomic reprogramming.
- INNACOL- PN-IV—P7-.7.1.-PED 2024 - Innovative substitutes with three-dimensional structure and antimicrobial activity based on collagen for craniofacial reconstruction .
- ReGenTACol - PN-IV-P7-7.1-PED- Development of an innovative collagen-based matrix with improved properties, intended for encapsulating pancreatic islets for transplantation
- SEARCH -VASC- PN-IV-P6-6.1-CoEx-2024-0029 - Center of Excellence in Advanced Translational Research in Cardiovascular and Neurovascular Diseases
- DIATARGET - PN-IV-P2-2.1-TE-2023-1203 - Exploring the role of long non-coding RNAs as potential targets in diabetes-associated aortic valve disease
National